Navigation Links
UP Government Fixes Work Schedules for Provincial Medical Service Doctors

opaedic surgeon should conduct at least 50 surgeries. The ultra-sound tests and X-rays have also been fixed at around 75 and 120 every month at the district hospital. And the doctors at the district women's hospitals have been asked to conduct at least 50 surgeries every month.

Dr Shantimal Singhavi the Chief Medical Officer has said that in observance to the order a circular had been issued to the CHC superintendents, chief medical superintendents of district hospitals and PHC heads. He explained that the main objective of the order was to ensure that medical and health services reaches to a large number of patients. He further stated that this order would also ensure that the government doctors would be more serious in going about their duties. He also added that with the standards of work expected being fixed, there would be strict action taken against all the medical officers who fall behind targets. He also warned that there would be an efficient system to ensure that the patient’s data would not be tampered with.
'"/>




Page: 1 2

Related medicine news :

1. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
2. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
3. Tanzanian Government Sanctions $20 Million For AIDS Arug
4. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
5. Indian Government warns Gujarat regarding possibility of bird flu
6. Indian Government Sets Up Task Force For Avian flu
7. Delhi Government To Interlink All Major Hospitals Through e-Governance
8. Kerala Government is in High Alert for Bird Flu
9. Philippines Government prepares to counter bird flu
10. Government Takes Tough Stand Against Falling Sex Ratio
11. Avian Influenza: Government to set up expert committee

Post Your Comments:
(Date:11/8/2009)... Freeze-drying of biopharmaceuticals to be avail...acility. , Toronto, ON (...nt and CEO of Therapure Biopharma Inc. today annou...ercial scale pharmaceutical grade freeze dryer and...yophilization) available for contract manufacturin...
(Date:11/8/2009)...s not mean the battle is won," said Dr. Charmaine ...swire/ -- In a vote of 240-194, the Stupak-Ellswor...t to prohibit abortion mandates and funding in HR ...ited for Life Action President and CEO Dr. Charmai... victory for the pro-life Americans across this co...
(Date:11/8/2009)...Passage of H.R. 3961 to Secure the Stability of Me...re/ -- Statement Attributable to: J. James Rohack,..., (Logo: http://www.newscom.com/cgi-bin/prnh/2...ge of the House health reform bill, which will hel...cians and calls for swift passage of H.R. 3961 to ...
(Date:11/8/2009)...se Passage of Health Care Reform Bill ,, Crit...e coverage for all Americans ,, BALTIMORE, Nov...the United States House of Representatives passed ... strengthen Medicare for seniors and end discrimin...of Americans out of affordable health coverage. ,...
(Date:11/7/2009)... The American Medical As...sh Award for Citizenship and Community Service to ...ago, IL. The award recognizes physicians who have ...uty to make an outstanding public service contribu...the award today during the opening session of the ...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
...uster Active Noise Reduction Earmuff Delivers Best...The NoiseBuster Active Noise Reduction ("ANR") Saf... noise generated by lawn, landscape and garden pow...scape construction, sports-field site development ...
... 23 Consider how these outlooks could free you fr... change the way you look at them. , Problems... , , , "Thus I Became Stress Free, Oh Really?...and happiness. Written from the inspiration Joshi ...
...alist HIDI(TM) process at the 2009 Annual Congress..., , SEATTLE, March 23 Hospital executives find t...ith almost 50 percent of America,s hospitals now o...y and retaining physicians and caregivers. The cha...
...orphotek(R), Inc., a subsidiary of Eisai Corporati... Food and Drug Administration (FDA) has agreed to ...e III clinical trial evaluating farletuzumab (also... Assessment (SPA) procedure. , , "We are pleased ...
...h.D. Honored for Distinguished Service in the Fiel...NovaBay Pharmaceuticals, Inc. (NYSE Alternext: NBY... Frederick Hawthorne, Ph.D., a member of the Compa...r. Hawthorne, who is co-director of the Internatio...
...wire-FirstCall/ - Transition Therapeutics Inc. ("T...TTH) announced today that the first patient has be...T-223 in combination with a proprietary Lilly GLP-...ate the safety, tolerability and efficacy of daily...
Other Medicine News:Health News:NoiseBuster(R) Safeguards Hearing by Utilizing Cutting-Edge Technology to Attenuate Power Equipment Noise 2Health News:'Thus I Became Stress Free, Oh Really?': Systematically Manage and Optimize Stress to Improve Productivity, Happiness 2Health News:Sound Inpatient Physicians Report on New Clinical Processes to Reduce Healthcare Costs and Enhance Care 2Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 2Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 3Health News:Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 4Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 2Health News:NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award 3Health News:Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 2
(Date:11/7/2009)... BEACH, Fla., Nov. 7 Patients repo... an effective therapy in treating acute swelling a...rious genetic disorder, according to data presente...sthma & Immunology (ACAAI) Annual Meeting. The...nts conducted in parallel with the ongoing, prospe...
(Date:11/6/2009)...LL, Wash., Nov. 6 SCOLR ...l results for the three and nine months ended Sept...harma,s President and CEO, said, "We continue to a...r ibuprofen formulation. Several potential partner...rsonnel and external resources as they evaluate th...
(Date:11/6/2009)...OUIS, Nov. 6 Recession i...depress sales for Allied Healthcare Products in th...er 30, 2009. ,, Sales declines pushed Allied in...uarter was about $745,000, or negative 9 cents per...of about $208,000, or 3 cents per share. ,, Sa...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Discovering soybean plants resistant to aphids and a new aphid 9530 1Discovering soybean plants resistant to aphids and a new aphid 9530 2Discovering soybean plants resistant to aphids and a new aphid 9530 3Discovering soybean plants resistant to aphids and a new aphid 9530 4PLUS Diagnostics Announces Senior Executive Appointments 54089 1PLUS Diagnostics Announces Senior Executive Appointments 54089 2PLUS Diagnostics Announces Senior Executive Appointments 54089 3Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 1Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 2Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 3
... (Zurich), Switzerland, May 24, 2007 - Cytos,Biote... a,placebo-controlled, double-blind combined phase...ndidate for the treatment of,psoriasis and other i...rst-time-in-man clinical trial and included 48 pat...riasis. In a first part,of the study, the safety a...
... Mass.--(BUSINESS WIRE)--May 24, 2007 - ImmunoGen,...that develops targeted,anticancer therapeutics usi...oday announced that clinical findings for three,di...umors are to be,reported at the 43rd American Soci...take place June 1-5, 2007 in Chicago, IL., Trastuz...
Other Medicine Technology:Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 2Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 3Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 4ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3
Agarose, ultra high resolution, Molecular Biology Grade
AGAROSE I (Molecular Biology Grade)
Agarose, 500g
Agarose NA
Medicine Products: